| First Author | Kashihara T | Year | 2022 |
| Journal | J Clin Invest | Volume | 132 |
| Issue | 6 | PubMed ID | 35133975 |
| Mgi Jnum | J:322295 | Mgi Id | MGI:7257696 |
| Doi | 10.1172/JCI150595 | Citation | Kashihara T, et al. (2022) YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. J Clin Invest 132(6):e150595 |
| abstractText | The heart utilizes multiple adaptive mechanisms to maintain pump function. Compensatory cardiac hypertrophy reduces wall stress and oxygen consumption, thereby protecting the heart against acute blood pressure elevation. The nuclear effector of the Hippo pathway, Yes-associated protein 1 (YAP), is activated and mediates compensatory cardiac hypertrophy in response to acute pressure overload (PO). In this study, YAP promoted glycolysis by upregulating glucose transporter 1 (GLUT1), which in turn caused accumulation of intermediates and metabolites of the glycolytic, auxiliary, and anaplerotic pathways during acute PO. Cardiac hypertrophy was inhibited and heart failure was exacerbated in mice with YAP haploinsufficiency in the presence of acute PO. However, normalization of GLUT1 rescued the detrimental phenotype. PO induced the accumulation of glycolytic metabolites, including l-serine, l-aspartate, and malate, in a YAP-dependent manner, thereby promoting cardiac hypertrophy. YAP upregulated the GLUT1 gene through interaction with TEA domain family member 1 (TEAD1) and HIF-1alpha in cardiomyocytes. Thus, YAP induces compensatory cardiac hypertrophy through activation of the Warburg effect. |
